Literature DB >> 2316562

The case for routine umbilical blood acid-base studies at delivery.

J W Johnson1, D S Richards, R A Wagaman.   

Abstract

One of the major goals of obstetricians is to prevent fetal asphyxia. Unfortunately, the commonly used clinical indicators (fetal heart rate monitoring, meconium staining of the amniotic fluid, and Apgar scores) do not have acceptable accuracy in establishing the presence of fetal asphyxia. These subjective assessments often overdiagnose fetal asphyxia and on occasion may fail to detect its presence. The only scientific, objective means of diagnosing fetal asphyxia at delivery is through umbilical blood acid-base studies. This test is convenient, noninvasive, and accurate. The routine use of umbilical blood acid-base studies is a major asset to the obstetric team in determining (1) the presence of asphyxia and its consequences, (2) the efficacy of interventions to prevent fetal asphyxia, and (3) the mechanisms responsible for fetal acidosis.

Entities:  

Mesh:

Year:  1990        PMID: 2316562     DOI: 10.1016/0002-9378(90)90970-i

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Cord and placenta arterial gas analysis: the accuracy of delayed sampling.

Authors:  Adrienne Lynn; Philip Beeby
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-10-30       Impact factor: 5.747

2.  Erythropoietin concentrations and erythropoiesis in newborns suffering from renal agenesis and congenital kidney diseases.

Authors:  H Fahnenstich; C Dame
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

3.  The Scottish perinatal neuropathology study: clinicopathological correlation in early neonatal deaths.

Authors:  J C Becher; J E Bell; J W Keeling; N McIntosh; B Wyatt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

4.  Effect of Weight-Adjusted Phenylephrine, Norepinephrine, and Metaraminol for Elective Cesarean Delivery on Neonatal Acid-Base Status: A Randomized Controlled Trial.

Authors:  Tianyu Liu; Zhiyong Cheng; Shiya Zou; Chao Xu; Shoudong Pan; Huabei Zeng; Yidong Shan; Yi Feng; Hong Zhang
Journal:  Drug Des Devel Ther       Date:  2022-09-21       Impact factor: 4.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.